Crossmark

Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort

Crossref DOI link: https://doi.org/10.1186/s12959-021-00286-7

Published Online: 2021-05-31

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mulder, Mark M. G. https://orcid.org/0000-0002-6485-8060
Brandts, LIoyd https://orcid.org/0000-0002-0620-1271
Brüggemann, Renée A. G. https://orcid.org/0000-0003-1482-4708
Koelmann, Marcel

Streng, Alexander S.

Olie, Renske H. https://orcid.org/0000-0002-4710-9236
Gietema, Hester A. https://orcid.org/0000-0001-6077-1446
Spronk, Henri M. H. https://orcid.org/0000-0002-3858-334X
van der Horst, Iwan C. C. https://orcid.org/0000-0003-3891-8522
Sels, Jan-Willem E. M.

Wildberger, Joachim E. https://orcid.org/0000-0002-4810-6854
van Kuijk, Sander M. J. https://orcid.org/0000-0003-2796-729X
Schnabel, Ronny M. https://orcid.org/0000-0001-8410-332X
ten Cate, Hugo https://orcid.org/0000-0001-7796-4463
Henskens, Yvonne M. C.

van Bussel, Bas C. T. https://orcid.org/0000-0003-1621-7848
License Information

Text and Data Mining valid from 2021-05-31

Version of Record valid from 2021-05-31
More Information

Article History

Received: 25 February 2021

Accepted: 7 May 2021

First Online: 31 May 2021

Declarations

:

: The local institutional review board (Medisch Ethische Toetsingscomissie (METc) 2020–1565/ 300523) of the Maastricht UMC+ waived consent and approved the study, which was performed based on the regulations of Helsinki. The study is registered in the Netherlands Trial Register (registration number NL8613).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below